Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4826
RYTHM Inc
RYM
$34.5M
| $4.47K | ﹤0.01% |
+213
| New | +$4.72K |
2026 Q3
0 quarters
|
|
|
AZR
4827
Azora Therapeutics, Inc. Common Stock
AZR
$10.5M
| $4.39K | ﹤0.01% |
+1,094
| New | +$4.7K |
2026 Q3
0 quarters
|
|
4828
Fractyl Health
GUTS
$12.3M
| $4.38K | ﹤0.01% |
670
+515
| +332% | +$4.27K |
2025 Q4
3 quarters
|
|
4829
ADS-TEC Energy
ADSE
$692M
| $4.21K | ﹤0.01% |
383
| – | – |
2024 Q4
7 quarters
|
|
4830
Cadrenal Therapeutics
CVKD
$3.5M
| $4.2K | ﹤0.01% |
3,886
+3,793
| +4,078% | +$6.88K |
2026 Q2
1 quarter
|
|
4831
Pioneer Acquisition I Corp Units
PACHU
$231M
| $4.15K | ﹤0.01% |
+400
| New | +$4.15K |
2026 Q3
0 quarters
|
|
4832
AleAnna Inc
ANNA
$83.5M
| $3.99K | ﹤0.01% |
+1,513
| New | +$4.46K |
2026 Q3
0 quarters
|
|
4833
Rithm Property Trust
RPT
$87M
| $3.96K | ﹤0.01% |
370
-710
| -66% | -$8.85K |
2024 Q3
8 quarters
|
|
4834
Gaia
GAIA
$32.8M
| $3.94K | ﹤0.01% |
2,987
-754
| -20% | -$1.25K |
2024 Q4
7 quarters
|
|
4835
PermRock Royalty Trust Unit
PRT
$17.3M
| $3.8K | ﹤0.01% |
1,970
| – | – |
2024 Q1
10 quarters
|
|
4836
GRAVITY
GRVY
$467M
| $3.74K | ﹤0.01% |
+56
| New | +$3.77K |
2026 Q3
0 quarters
|
|
4837
MicroCloud Hologram
HOLO
$25M
| $3.74K | ﹤0.01% |
+2,336
| New | +$3.82K |
2026 Q3
0 quarters
|
|
4838
Launch One Acquisition Corp Unit
LPAAU
| $3.72K | ﹤0.01% |
344
| – | – |
2024 Q3
8 quarters
|
|
4839
Innovator Equity Dual Directional 10 Buffer ETF - November
DDTN
$35.5M
| $3.62K | ﹤0.01% |
173
-2,113
| -92% | -$43.8K |
2026 Q2
1 quarter
|
|
4840
Telkom Indonesia
TLK
$10.9B
| $3.47K | ﹤0.01% |
272
-6,362
| -96% | -$92K |
2025 Q3
4 quarters
|
|
4841
Inovio Pharmaceuticals
INO
$126M
| $3.45K | ﹤0.01% |
2,826
-661
| -19% | -$737 |
2024 Q2
9 quarters
|
|
4842
Euroholdings Ltd
EHLD
$32.7M
| $3.4K | ﹤0.01% |
290
| – | – |
2025 Q1
6 quarters
|
|
4843
Innovator Equity Dual Directional 10 Buffer ETF - September
DDTS
$40.6M
| $3.24K | ﹤0.01% |
141
| – | – |
2026 Q2
1 quarter
|
|
4844
PUT
Core Scientific
CORZ
$3.78B
| $3.2K | ﹤0.01% |
+200
| New | +$3.94K |
2026 Q3
0 quarters
|
|
4845
Soulpower Acquisition Corp Units
SOUL.U
| $3.15K | ﹤0.01% |
295
-105
| -26% | -$1.11K |
2025 Q4
3 quarters
|
|
4846
IRSA Inversiones y Representaciones
IRS
$1.06B
| $3.15K | ﹤0.01% |
226
| – | – |
2026 Q1
2 quarters
|
|
4847
Cumberland Pharmaceuticals
CPIX
$78.2M
| $3.09K | ﹤0.01% |
395
+347
| +723% | +$2.52K |
2026 Q2
1 quarter
|
|
4848
AllianzIM U.S. Equity Buffer10 Nov ETF
NVBT
$27.7M
| $2.93K | ﹤0.01% |
72
| – | – |
2026 Q2
1 quarter
|
|
4849
Scilex Holding
SCLX
$12M
| $2.74K | ﹤0.01% |
+616
| New | +$3.98K |
2026 Q3
0 quarters
|
|
4850
HF Foods Group
HFFG
$81.7M
| $2.57K | ﹤0.01% |
1,569
-835
| -35% | -$1.4K |
2019 Q2
29 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.